Preparation method of androxib and intermediates of androxib

By precisely controlling reaction conditions and solvent use, the method enhances the purity and yield of Amlexanox intermediates, addressing quality control issues in existing preparation methods.

CN119080727APending Publication Date: 2024-12-06BEIJING SUN-NOVO PHARM RES CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411354309.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-27
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

Existing methods for preparing Amlexanox and its intermediates fail to adequately control the quality, particularly the purity and yield, of key intermediates such as 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile (YAL-SM), leading to suboptimal performance in the final product.

Method used

A refined method involving precise control of reaction conditions, including solvent selection and ratios, temperature, and crystallization processes for YAL-SM and subsequent intermediates, such as using N,N-dimethylformamide (DMF) with specific solid-liquid ratios and temperature ranges, ensures high purity and yield.

Benefits of technology

The method effectively controls impurity content while maintaining high yield, resulting in improved quality and performance of Amlexanox intermediates and the final product.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005063156410000011
    Figure BDA0005063156410000011
  • Figure BDA0005063156410000041
    Figure BDA0005063156410000041
  • Figure BDA0005063156410000042
    Figure BDA0005063156410000042
Patent Text Reader

Abstract

The invention discloses a refining method of an Annolix intermediate, which comprises the following steps: pretreatment: mixing a 6-isopropyl-4-oxo-4H-1-benzopyran-3-formonitrile crude product with N, N-dimethylformamide, stirring under a heating condition until the 6-isopropyl-4-oxo-4H-1-benzopyran-3-formonitrile crude product is completely dissolved, filtering, washing, and drying to obtain a crude product of 6-isopropyl-4-oxo-4H-1-benzopyran-3-formonitrile; the preparation method comprises the following steps: mixing a raw material 6-isopropyl-4-oxo-4H-1-benzopyran-3-formonitrile with a solvent, then cooling the mixture to crystallize, repeatedly treating for 1-2 times to obtain a 6-isopropyl-4-oxo-4H-1-benzopyran-3-formonitrile wet product, drying the 6-isopropyl-4-oxo-4H-1-benzopyran-3-formonitrile wet product to obtain the 6-isopropyl-4-oxo-4H-1-benzopyran-3-formonitrile, and meanwhile, separating out the 6-isopropyl-4-oxo-4H-1-benzopyran-3-formonitrile. The invention provides the preparation method for producing the anlenolix according to the anlenolix intermediate, the yield of the obtained anlenolix intermediate is high, the content of related substances is low, and meanwhile, the yield and the purity of the anlenolix are more excellent.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application belongs to the field of pharmaceutical preparations, and specifically relates to a method for preparing Anlenox and its intermediates. Background Art

[0002] Anlenox, the Chinese chemical name is 2-amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid, also known as Amlexanox, CAS number: 68302-57-8, the chemical structure is as follows:

[0003]

[0004] Amlexanox is a drug with anti-inflammatory and antiallergic activity that has been studied for the treatment of recurrent oral ulcers. Amlexanox reduces the symptoms of oral ulcers and promotes healing by inhibiting the synthesis and release of inflammatory mediators in mast cells, neutrophils, and monocytes.

[0005] In 2010, Chen Aijun et al. (Synthesis of Amlexanox; Applied Chemical Industry, VOL39, NO2, hereinafter referred to as Document 1) reported that 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile (hereinafter referred to as YAL-SM) was a key intermediate in the synthesis process of two kinds of Amlexanox, and by adjusting the amount of phosphorus oxychloride and controlling the reaction at -5 to 5°C, the yield of YAL-SM was increased to more than 70%. However, the report did not examine the quality of YAL-SM. Although the yields of YAL-SM and Amlexanox were improved, their purity and related substances were not verified.

[0006] Patent CN116444533A discloses a method for refining amlexanox, which solves the problem of residual solvent in the preparation process of amlexanox by using DMSO.

[0007] It can be seen that there are still many aspects that need to be improved in the quality control of Amlexanox and its key intermediates. Summary of the invention

[0008] In order to solve the problems existing in the prior art, the present invention provides the following technical solutions:

[0009] A method for refining an Anlenox intermediate comprises the following steps:

[0010] Pretreatment: mixing a crude 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile with N,N-dimethylformamide, stirring under heating conditions until the crude 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile is completely dissolved, then cooling the mixture for crystallization, repeating the process 1 to 2 times to obtain a wet product of 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile, and drying the wet product of 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile to obtain 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile;

[0011] Wherein, the solid-liquid ratio of the 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile to the N,N-dimethylformamide is 1:(2-3).

[0012] Furthermore, in the pretreatment, the heating condition is at a temperature of 40 to 60°C.

[0013] In another aspect, the present invention provides a method for preparing Anlenox, comprising the following steps:

[0014] Step 1): reacting the 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile obtained by pretreatment with ethyl cyanoacetate to generate 2-amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid ethyl ester;

[0015] Step 2): dissolving the 2-amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid ethyl ester obtained in step 1) in anhydrous ethanol under the action of piperidine, and then adding sodium hydroxide to react to obtain a crude product of Anlenox;

[0016] Step 3): The crude product of Anlenox obtained in step 2) is purified to obtain Anlenox.

[0017] Further, the step 3) is performed as follows:

[0018] The crude product of Anlenox is mixed with N,N-dimethylformamide, stirred and slurried under heating conditions, and then the mixture is cooled and crystallized, and drained until no liquid drips out to obtain wet product 1; then, a slurrying solvent is added to the wet product 1 to control the temperature and slurry, and wet product 2 is obtained after filtering, eluting, and draining, and the wet product 2 is dried to obtain Anlenox.

[0019] Furthermore, in the step 3), the solid-to-liquid ratio of the crude Anlenox to the N,N-dimethylformamide is 1:(5-6).

[0020] Furthermore, in the step 3), the solid-to-liquid ratio of the crude Anlenox to the pulping solvent is 1:(5-7).

[0021] Furthermore, the pulping solvent in the step 3) is purified water.

[0022] Furthermore, the temperature of the heating condition in the step 3) is 85-95°C.

[0023] Furthermore, in the step 3), the temperature of the cooling and crystallization is 15-20°C.

[0024] In another aspect, the present invention provides Anlenox prepared according to the above method.

[0025] Compared with the prior art, the preparation method of Anlenox of the present invention has the following advantages:

[0026] The present invention successfully controls the content of related impurities while ensuring the yield of the key intermediate YAL-SM of Anlenox by finely controlling the reaction temperature, material ratio and solvent selection, and significantly improves the purity of YAL-SM. In addition, Anlenox produced by YAL-SM prepared by the present invention has achieved better performance in terms of yield and purity. DETAILED DESCRIPTION

[0027] The technical solutions in the embodiments of the present application will be described clearly below. Obviously, the described embodiments are part of the embodiments of the present application, not all of the embodiments. All other embodiments obtained by ordinary technicians in this field based on the embodiments in the present application belong to the scope of protection of the present application.

[0028] The terms "first", "second", etc. in the specification and claims of this application are used to distinguish similar objects, and are not used to describe a specific order or sequence. It should be understood that the data used in this way can be interchangeable under appropriate circumstances, so that the embodiments of the present application can be implemented in an order other than those described here, and the objects distinguished by "first", "second", etc. are generally of one type, and the number of objects is not limited. For example, the first object can be one or more. In addition, "and / or" in the specification and claims represents at least one of the connected objects, and the character " / " generally indicates that the objects associated before and after are in an "or" relationship.

[0029] Unless otherwise specified, the experimental methods used in the following examples and comparative examples are conventional methods; the reagents, materials, etc. used in the following examples and comparative examples, unless otherwise specified, can be obtained from commercial sources. The crude 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile (hereinafter referred to as YAL-SM-CP) of the present invention is prepared by the method described in document 1.

[0030] The present invention relates to a method for preparing YAL-SM-CP (hereinafter referred to as YAL) by subjecting YAL-SM-CP obtained in Document 1 to a specific pretreatment. The specific preparation method comprises:

[0031] Pretreatment: YAL-SM-CP is mixed with DMF, and stirred under heating conditions until YAL-SM-CP is completely dissolved, and then the mixture is cooled and crystallized, and the treatment is repeated 1 to 2 times to obtain a YAL-SM wet product, and the YAL-SM wet product is dried to obtain YAL-SM;

[0032] Specifically,

[0033] In one embodiment of the present invention, the solid-liquid ratio of the YAL-SM to the DMF is 1: (2-3), for example 1: 2 or 1: 3, but is not limited to the listed values, and other unlisted values ​​within the numerical range are also applicable. After repeated experiments, the inventors found that the amount of DMF used has a crucial influence on the reaction process and the quality of YAL-SM. When the dosage is insufficient, the reactants may not be fully dissolved, affecting the completeness and efficiency of the reaction; and excessive dosage may cause the YAL-SM yield to decrease. Therefore, precise control of the amount of DMF used is crucial to ensuring the quality of the final product. The solid-liquid ratio described in the present invention refers to the ratio of the mass of solid matter to the volume of liquid matter.

[0034] In one embodiment of the present invention, in the pre-treatment, the temperature of the heating condition is 40 to 60°C, for example, 40°C, 50°C or 60°C, but is not limited to the listed values, and other unlisted values ​​within the numerical range are also applicable. This temperature range has a direct and critical impact on the quality of YAL-SM products. If the temperature is too high, the structure of the reaction raw materials may be damaged, thereby affecting the stability and activity of the product; conversely, if the temperature is too low, it may be detrimental to the full progress of the reaction, thereby reducing the overall quality of the product. Therefore, precise control of the heating temperature has become a key link in ensuring the quality of YAL-SM products.

[0035] YAL-SM, as a key intermediate in the preparation of YAL, will directly affect the quality of the final YAL, especially the purity. The inventors not only controlled the impurity content of the final YAL, but also effectively improved the yield of the final product by performing specific pre-treatment on YAL-SM and then performing subsequent reactions.

[0036] Step 1): The YAL-SM obtained by pretreatment is reacted with ethyl cyanoacetate (hereinafter referred to as "YAL-SM-B") under the action of piperidine to generate 2-amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid ethyl ester (hereinafter referred to as "YAL-1"), and the reaction equation is as follows:

[0037]

[0038] Step 2): Dissolve the YAL-1 obtained in step 1) in anhydrous ethanol, then add sodium hydroxide to react to obtain a crude product of Anlenox (hereinafter referred to as "YAL-CP"); reaction equation:

[0039]

[0040] Step 3): The YAL-CP obtained in step 2) is purified to obtain YAL.

[0041] Specifically, the step 3) is performed as follows:

[0042] YAL-CP is mixed with DMF, stirred and slurried under heating conditions, and then the mixture is cooled and crystallized, and drained until no liquid drips out to obtain wet product 1; then a slurrying solvent is added to the wet product 1 to control the temperature and slurry, and wet product 2 is obtained after filtering, eluting and draining, and the wet product 2 is dried to obtain YAL.

[0043] In one embodiment of the present invention, the solid-liquid ratio of YAL-CP to DMF in the step 3) operation is 1: (5-6), such as 1: 5 or 1: 6, but it is not limited to the listed values, and other values ​​not listed in the numerical range are also applicable. The inventors compared a variety of commonly used solvents in the experiment, including toluene, NMP (N-methylpyrrolidone), etc. The results showed that only DMF can effectively control the content of related substances while ensuring the yield of the final product YAL. In one embodiment of the present invention, the solid-liquid ratio of YAL-CP to the pulping solvent in the step 3) operation is 1: (5-7), such as 1: 5, 1: 6 or 1: 7, but it is not limited to the listed values, and other values ​​not listed in the numerical range are also applicable. Too low a pulping solvent will cause the impurity content in the final product YAL to be too high, and too high a pulping solvent content will increase the difficulty of the subsequent separation and drying process, and affect the quality of YAL. Selecting a suitable amount of pulping solvent is also very important for the quality of the final product. In one embodiment of the present invention, the pulping solvent is purified water.

[0044] In one embodiment of the present invention, the temperature of the heating condition is 85-95°C, such as 85°C, 90°C or 95°C, but is not limited to the listed values, and other unlisted values ​​within the numerical range are also applicable.

[0045] In one embodiment of the present invention, the temperature of the cooling crystallization is 15 to 20 ° C, such as 15 ° C, 17 ° C or 20 ° C, but is not limited to the listed values, and other unlisted values ​​within the numerical range are also applicable. The inventors tried to lower the crystallization temperature (such as 0 to 10 ° C) or increase the crystallization temperature (such as 25 ° C) in the experiment, but found that only by crystallizing in a temperature range of 15 to 20 ° C can the yield of the final product YAL be guaranteed and the content of related impurities be effectively controlled. Too high a temperature is also not conducive to the crystallization process, and the expected purification purpose cannot be achieved.

[0046] In the preparation process of Anlenox, the inventors precisely controlled many key factors of YAL-SM pretreatment, including the type of solvent, treatment temperature, and material dosage. With the help of specific pretreatment conditions, the obtained YAL-SM was used in the preparation of YAL. The final YAL not only had a high yield, but also the impurity content was effectively controlled at a low level.

[0047] The following are specific examples of the present invention and comparative examples, but the present invention is not limited to the following examples.

[0048] Example 1

[0049] Pre-treatment:

[0050] Treatment 1: Add YAL-SM-CP (2.99 kg) and DMF (5.98 L) to a 20 L reactor, stir and heat to 50-60 °C to dissolve. Slowly drop purified water (1.50 L) into the reaction solution. After the drop is complete, the solid precipitates and stir for 1 h. Cool the reaction system to 15-20 °C and stir to crystallize for 1 h. Filter and drain until no liquid drips out.

[0051] Treat twice: Add the wet product obtained by the above step once and DMF (5.98L) to a 20L reactor in turn, stir and heat to 50-60℃, stir and dissolve. Slowly add purified water (1.50L) ​​to the reaction solution, and after the dropwise addition, the solid precipitates and stir for 1h. Cool the reaction system to 15-20℃ and stir and crystallize for 1h. Filter and drain until no liquid drips out. Rinse the filter cake again with purified water (1.50L) ​​and drain until no liquid drips out.

[0052] Quenching & post-treatment: Collect the wet product and place it in a vacuum drying oven at 55-65°C for 4 hours for sampling and testing, until the rapid drying weight loss is ≤1% (rapid drying weight loss 105°C / 5min), and obtain a white solid YAL-SM.

[0053] Step 1):

[0054] Ring-closing reaction: add anhydrous ethanol (32.2L), piperidine (0.95kg), YAL-SM-B (1.72kg), and YAL-SM obtained by pretreatment (2.32kg) into a 100L reactor, start stirring and heating. Control the temperature at 75-85℃ and react for 1-3h until the reaction is complete.

[0055] Quenching & post-treatment: After the ring-closing reaction is completed, turn off the heating, cool the reaction system to 0-5°C, stir and crystallize for 1 hour. Filter and use anhydrous ethanol (2.3L) to complete the rinse transfer. Add the wet solid to anhydrous ethanol (23.2L) again, and control the temperature at 75-85°C to slurry for 1 hour. Reduce the temperature to -5--15°C, stir and crystallize for 30 minutes, centrifuge, and use anhydrous ethanol (4.6L) to complete the rinse transfer. Put the wet solid into a vacuum drying oven at 80-90°C and dry it for 4 hours, then take samples for testing, and collect the material when the rapid drying weight loss is ≤1% (rapid drying weight loss 105°C / 5min) to obtain an off-white solid YAL-1.

[0056] Step 2):

[0057] Hydrolysis reaction: add anhydrous ethanol (66.0 L) and YAL-1 (3.30 kg) obtained in step 1) into a 100 L reactor and start stirring. Add 2N NaOH aqueous solution (33.0 L), start heating, and control the temperature at 45-55°C to react. TLC detection is performed until the reaction is complete.

[0058] Quenching & post-treatment: After the hydrolysis reaction is completed, turn off the heating, control the temperature not higher than 50°C, and slowly add concentrated hydrochloric acid (7.0L) until the system pH = 5-6. After the addition, control the temperature at 0-5°C and stir to crystallize for 1h, centrifuge until no liquid drips out. Use anhydrous ethanol (6.6L) to rinse the filter cake, put it into a vacuum drying oven at 80-90°C and dry it for 4h, take samples for testing, and collect the material when the rapid drying weight loss is ≤1% (rapid drying weight loss 105°C / 5min), and obtain an off-white solid YAL-CP.

[0059] Step 3):

[0060] Refining reaction: Add YAL-CP (2.92kg) and DMF (17.5L) obtained in step 2) to a 20L reactor in sequence, start stirring and heat to 85-95°C for stirring and beating for 1h. Turn off the heating, cool the reaction system to 15-20°C and stir and crystallize for 1h. Filter and drain until no liquid drips out. Collect the wet product and add it to the reaction bottle again, and add purified water (14.6L) to the reaction bottle. Turn on stirring and control the temperature at 15-20°C for stirring and beating for 1h, filter, and drain until no liquid drips out. Use purified water (1.5L) to rinse the filter cake and drain again until no liquid drips out.

[0061] Quenching & post-treatment: The wet product was placed in a vacuum drying oven at 80-90°C for 4 hours and then sampled for testing until the rapid drying weight loss was ≤1% (rapid drying weight loss 105°C / 5min) to obtain a white solid, namely YAL.

[0062] Example 2

[0063] Pre-treatment:

[0064] Treatment 1: Add YAL-SM-CP (2.99 kg) and DMF (8.97 L) to a 20 L reactor, stir and heat to 50-60 °C to dissolve. Slowly drop purified water (1.50 L) into the reaction solution. After the drop is complete, the solid precipitates and stir for 1 h. Cool the reaction system to 15-20 °C and stir to crystallize for 1 h. Filter and drain until no liquid drips out.

[0065] Treat twice: Add the wet product obtained by the above step once and DMF (8.97L) to a 20L reactor in turn, stir and heat to 50-60℃, stir and dissolve. Slowly add purified water (1.50L) ​​to the reaction solution, and after the dropwise addition, the solid precipitates and stir for 1h. Cool the reaction system to 15-20℃ and stir and crystallize for 1h. Filter and drain until no liquid drips out. Rinse the filter cake again with purified water (1.50L) ​​and drain until no liquid drips out.

[0066] Quenching & post-treatment: Collect the wet product and place it in a vacuum drying oven at 55-65°C for 4 hours for sampling and testing, until the rapid drying weight loss is ≤1% (rapid drying weight loss 105°C / 5min), and obtain a white solid YAL-SM.

[0067] The process steps and conditions of step 1) to step 3) are the same as those in Example 1.

[0068] Example 3

[0069] Pre-treatment:

[0070] Treatment 1: Add YAL-SM-CP (2.99 kg) and DMF (5.98 L) to a 20 L reactor, stir and heat to 40-50 °C to dissolve. Slowly drop purified water (1.50 L) into the reaction solution. After the drop is complete, the solid precipitates and stir for 1 h. Cool the reaction system to 15-20 °C and stir to crystallize for 1 h. Filter and drain until no liquid drips out.

[0071] Treat twice: Add the wet product obtained by the above step once and DMF (5.98L) to a 20L reactor in turn, stir and heat to 40-50℃, stir and dissolve. Slowly add purified water (1.50L) ​​to the reaction solution, and after the dropwise addition, the solid precipitates and stir for 1h. Cool the reaction system to 15-20℃ and stir and crystallize for 1h. Filter and drain until no liquid drips out. Rinse the filter cake again with purified water (1.50L) ​​and drain until no liquid drips out.

[0072] Quenching & post-treatment: Collect the wet product and place it in a vacuum drying oven at 55-65°C for 4 hours for sampling and testing, until the rapid drying weight loss is ≤1% (rapid drying weight loss 105°C / 5min), and obtain a white solid YAL-SM.

[0073] The process steps and conditions of step 1) to step 3) are the same as those in Example 1.

[0074] Example 4

[0075] The process steps and conditions for the preparation of the pretreatment, step 1) and step 2) are the same as those in Example 1, and the preparation process of step 3) is as follows:

[0076] Refining reaction: Add YAL-CP (2.92kg) and DMF (17.5L) obtained in step 2) to a 20L reactor in sequence, start stirring and heat to 85-95°C for stirring and beating for 1h. Turn off the heating, cool the reaction system to 15-20°C and stir and crystallize for 1h. Filter and drain until no liquid drips out. Collect the wet product and add it to the reaction bottle again, and add purified water (20.44L) to the reaction bottle. Turn on stirring and control the temperature at 15-20°C for stirring and beating for 1h, filter, and drain until no liquid drips out. Use purified water (1.5L) to rinse the filter cake and drain again until no liquid drips out.

[0077] Quenching & post-treatment: The wet product was placed in a vacuum drying oven at 80-90°C for 4 hours and then sampled for testing until the rapid drying weight loss was ≤1% (rapid drying weight loss 105°C / 5min) to obtain a white solid, namely YAL.

[0078] Comparative Example 1

[0079] Pre-treatment:

[0080] Treatment 1: Add YAL-SM-CP (2.99 kg) and methanol (8.97 L) to a 20 L reactor, stir and heat to 60-70 °C, reflux and stir at this temperature for 1 hour, then cool the reaction system to 15-20 °C and stir and crystallize for 1 hour. Filter and drain until no liquid drips out.

[0081] Treatment 2 times: Add the wet product obtained in the above step 1 treatment and methanol (8.97L) to a 20L reactor in turn, stir and heat to 60-70℃, and reflux and stir at this temperature for 1 hour, then cool the reaction system to 15-20℃ and stir and crystallize for 1 hour. Filter and drain until no liquid drips out. Rinse the filter cake again with purified water (1.50L) ​​and drain until no liquid drips out.

[0082] Quenching & post-treatment: Collect the wet product and place it in a vacuum drying oven at 55-65°C for 4 hours for sampling and testing, until the rapid drying weight loss is ≤1% (rapid drying weight loss 105°C / 5min), and obtain a white solid YAL-SM.

[0083] The process steps and conditions of step 1) to step 3) are the same as those in Example 1.

[0084] Comparative Example 2

[0085] Pre-treatment:

[0086] Treatment 1: Add YAL-SM-CP (2.99 kg) and DMF (11.96) to a 20L reactor in turn and stir. Stir at room temperature (about 25°C) until dissolved. Slowly drop purified water (1.50L) ​​into the reaction solution. After the drop is complete, the solid precipitates and stir for 1h. Cool the reaction system to 15-20°C and stir for crystallization for 1h. Filter and drain until no liquid drips out.

[0087] Treat twice: Add the wet product obtained by the above step once and DMF (11.96) to a 20L reactor in turn, start stirring, and stir at room temperature (about 25°C) to dissolve. Slowly add purified water (1.50L) ​​to the reaction solution. After the dropwise addition, the solid precipitates and stir for 1h. Cool the reaction system to 15-20°C and stir to crystallize for 1h. Filter and drain until no liquid drips out. Rinse the filter cake again with purified water (1.50L) ​​and drain until no liquid drips out.

[0088] Quenching & post-treatment: Collect the wet product and place it in a vacuum drying oven at 55-65°C for 4 hours for sampling and testing, until the rapid drying weight loss is ≤1% (rapid drying weight loss 105°C / 5min), and obtain a white solid YAL-SM.

[0089] The process steps and conditions of step 1) to step 3) are the same as those in Example 1.

[0090] Comparative Example 3

[0091] Perform a pre-processing, the specific operations are as follows:

[0092] Treatment 1: Add YAL-SM-CP (2.99 kg) and DMF (5.98 L) to a 20 L reactor, stir and heat to 50-60 °C to dissolve. Slowly drop purified water (1.50 L) into the reaction solution. After the drop is complete, the solid precipitates and stir for 1 h. Cool the reaction system to 15-20 °C and stir to crystallize for 1 h. Filter and drain until no liquid drips out.

[0093] Quenching & post-treatment: Collect the wet product and place it in a vacuum drying oven at 55-65°C for 4 hours for sampling and testing, until the rapid drying weight loss is ≤1% (rapid drying weight loss 105°C / 5min), and obtain a white solid YAL-SM.

[0094] The process steps and conditions of step 1) to step 3) are the same as those in Example 1.

[0095] Comparative Example 4

[0096] The process steps and conditions for the preparation of the pretreatment, step 1) and step 2) are the same as those in Example 1, and the preparation process of step 3) is as follows:

[0097] Refining reaction: Add YAL-CP (2.92kg) obtained in step 2) and toluene (17.5L) to a 20L reactor in sequence, start stirring and heat to 85-95°C for stirring and beating for 1h. Turn off the heating, cool the reaction system to 15-20°C and stir and crystallize for 1h. Filter and drain until no liquid drips out. Collect the wet product and add it to the reaction bottle again, and add purified water (14.6L) to the reaction bottle. Turn on stirring and control the temperature at 15-20°C for stirring and beating for 1h, filter, and drain until no liquid drips out. Use purified water (1.5L) to rinse the filter cake and drain again until no liquid drips out.

[0098] Quenching & post-treatment: The wet product was placed in a vacuum drying oven at 80-90°C for 4 hours and then sampled for testing until the rapid drying weight loss was ≤1% (rapid drying weight loss 105°C / 5min) to obtain a white solid, namely YAL.

[0099] Comparative Example 5

[0100] The process steps and conditions for the preparation of the pretreatment, step 1) and step 2) are the same as those in Example 1, and the preparation process of step 3) is as follows:

[0101] Refining reaction: Add YAL-CP (2.92kg) obtained in step 2) and NMP (N-methylpyrrolidone) (17.5L) to a 20L reactor in sequence, start stirring and heat to 85-95°C for stirring and beating for 1h. Turn off the heating, cool the reaction system to 15-20°C and stir and crystallize for 1h. Filter and drain until no liquid drips out. Collect the wet product and add it to the reaction bottle again, and add purified water (14.6L) to the reaction bottle. Turn on stirring and control the temperature at 15-20°C for stirring and beating for 1h, filter, and drain until no liquid drips out. Use purified water (1.5L) to rinse the filter cake and drain again until no liquid drips out.

[0102] Quenching & post-treatment: The wet product was placed in a vacuum drying oven at 80-90°C for 4 hours and then sampled for testing until the rapid drying weight loss was ≤1% (rapid drying weight loss 105°C / 5min) to obtain a white solid, namely YAL.

[0103] Comparative Example 6

[0104] The process steps and conditions for the preparation of the pretreatment, step 1) and step 2) are the same as those in Example 1, and the preparation process of step 3) is as follows:

[0105] Refining reaction: Add YAL-CP (2.92kg) and DMF (17.5L) obtained in step 2) to a 20L reactor in sequence, start stirring and heat to 85-95°C for stirring and beating for 1h. Turn off the heating, cool the reaction system to 0-10°C and stir and crystallize for 1h. Filter and drain until no liquid drips out. Collect the wet product and add it to the reaction bottle again, and add purified water (14.6L) to the reaction bottle. Turn on stirring and control the temperature at 0-10°C for stirring and beating for 1h, filter, and drain until no liquid drips out. Use purified water (1.5L) to rinse the filter cake and drain again until no liquid drips out.

[0106] Quenching & post-treatment: The wet product is placed in a vacuum drying oven at 80-90°C and vacuum dried for 4 hours, and then samples are taken for testing. The material is collected when the rapid drying weight loss is ≤1% (rapid drying weight loss 105°C / 5min) to obtain a white solid, namely Anlenox.

[0107] Comparative Example 7

[0108] The process steps and conditions for the preparation of the pretreatment, step 1) and step 2) are the same as those in Example 1, and the preparation process of step 3) is as follows:

[0109] Refining reaction: Add YAL-CP (2.92kg) and DMF (17.5L) obtained in step 2) to a 20L reactor in sequence, start stirring and heat to 85-95°C for stirring and beating for 1h. Turn off the heating, cool the reaction system to 15-20°C and stir and crystallize for 1h. Filter and drain until no liquid drips out. Collect the wet product and add it to the reaction bottle again, and add purified water (8.76L) to the reaction bottle. Turn on stirring and control the temperature at 15-20°C for stirring and beating for 1h, filter, and drain until no liquid drips out. Use purified water (1.5L) to rinse the filter cake and drain again until no liquid drips out.

[0110] Quenching & post-treatment: The wet product was placed in a vacuum drying oven at 80-90°C for 4 hours and then sampled for testing until the rapid drying weight loss was ≤1% (rapid drying weight loss 105°C / 5min) to obtain a white solid, namely YAL.

[0111] Comparative Example 8

[0112] The process steps and conditions for the preparation of the pretreatment, step 1) and step 2) are the same as those in Example 1, and the preparation process of step 3) is as follows:

[0113] Refining reaction: Add YAL-CP (2.92kg) and DMF (17.5L) obtained in step 2) to a 20L reactor in sequence, start stirring and heat to 85-95°C for stirring and beating for 1h. Turn off the heating, cool the reaction system to 25°C and stir and crystallize for 1h. Filter and drain until no liquid drips out. Collect the wet product and add it to the reaction bottle again, and add purified water (14.6L) to the reaction bottle. Turn on stirring and control the temperature at 25°C for stirring and beating for 1h, filter, and drain until no liquid drips out. Use purified water (1.5L) to rinse the filter cake and drain again until no liquid drips out.

[0114] Quenching & post-treatment: The wet product is placed in a vacuum drying oven at 80-90°C and vacuum dried for 4 hours, and then samples are taken for testing. The material is collected when the rapid drying weight loss is ≤1% (rapid drying weight loss 105°C / 5min) to obtain a white solid, namely Anlenox.

[0115] Comparative Example 9

[0116] Referring to the patent CN116444533A Example 1 for refining amlexanox, the process steps and conditions for the preparation of pretreatment, step 1) and step 2) are the same as those in Example 1, and the specific operation of step 3) is as follows:

[0117] Step 1: Add 2.92 kg of crude amlexanox and 43.8 kg of DMF solution to a 500 ml clean four-necked bottle equipped with a mechanical stirrer, stir and heat to 50°C to dissolve all the solids, filter while hot, and collect filtrate A;

[0118] Step 2: Add 43.8 kg of purified water to the filtrate A, cool to 25°C, stir for 60 min, crystallize, filter, and dry the obtained solid at 80°C in vacuum for 4 hours;

[0119] Step 3: Dissolve the dried solid in 14.6 kg DMSO, heat to 55°C, stir until the solution becomes clear, and filter the solution while hot to obtain filtrate B;

[0120] Step 4: Add the filtrate B dropwise into 29.2 kg of anhydrous ethanol, control the dropping temperature at 15-20°C, and keep warm for 3 hours after the dropping is completed; then centrifuge to obtain YAL.

[0121] Determination of the yields of YAL-SM and YAL obtained in Examples 1 to 4 and Comparative Examples 1 to 9

[0122] The determination method is as follows:

[0123] YAL-SM refining yield: m YAL-SM / m YAL-SM-CP *100%

[0124] YAL purification yield = m YAL / m YAL-CP *100%

[0125] The yields of Anlenox obtained in Examples 1 to 4 and Comparative Examples 1 to 9 are shown in Table 1

[0126] Table 1

[0127]

[0128]

[0129] Determination of related substances of YAL-SM obtained in Examples 1 to 3 and Comparative Examples 1 to 3

[0130] The relevant substances were determined according to high performance liquid chromatography (General Rules 0512 of Part IV of the Chinese Pharmacopoeia 2020 Edition).

[0131] Test solution Take the product, dissolve it in acetonitrile and quantitatively dilute it to make a solution containing about 0.2 mg per 1 ml.

[0132] For the control solution, accurately measure an appropriate amount of the test sample solution and dilute it with acetonitrile to make a solution containing approximately 1 μg per 1 ml.

[0133] System suitability solution: Take an appropriate amount of YAL-SM-03, place it in a 50ml volumetric flask, add acetonitrile to dissolve and quantitatively dilute to make a solution containing approximately 0.2mg per 1ml as the impurity stock solution; take another appropriate amount of this product, dissolve it in acetonitrile, add an appropriate amount of impurity stock solution, and dilute with acetonitrile to make a solution containing approximately 0.2mg of YAL-SM and 0.15μg of YAL-SM-03 per 1ml.

[0134] Sensitivity solution: Accurately measure 1 ml of the control solution, place it in a 20 ml volumetric flask, add acetonitrile to dilute to the scale, and shake well.

[0135] The chromatographic conditions were as follows: octadecylsilane bonded silica gel was used as filler (Waters XBridge RP184.6mm×150mm, 3.5μm); 0.1% trifluoroacetic acid aqueous solution-acetonitrile (60:40) was used as mobile phase; the flow rate was 1.0ml per minute; the column temperature was 30°C; the detection wavelength was 225nm; and the injection volume was 20μl.

[0136] System suitability requirements: In the system suitability solution chromatogram, the separation between substances should meet the requirements; in the sensitivity solution chromatogram, the signal-to-noise ratio of the main component peak height should be greater than 10.

[0137] Determination method: Accurately measure the test solution and the reference solution, inject them into the liquid chromatograph respectively, and record the chromatogram to 3 times the retention time of the main component peak.

[0138] If there are impurity peaks in the chromatogram of the limit test solution, the peak area of ​​YAL-SM-03 multiplied by the correction factor 1.2 shall not be greater than 0.3 times (0.15%) the main peak area of ​​the control solution, and other individual impurities shall not be greater than the main peak area of ​​the control solution (0.5%). The sum of the peak areas of all impurities calculated based on the corrected peak area shall not be greater than 2 times (1.0%) the main peak area of ​​the control solution.

[0139] Table 2

[0140]

[0141]

[0142] Table 3 Information on related substances of YAL-SM and YAL-SM crude product obtained in Examples 1 to 3 and Comparative Examples 1 to 3

[0143]

[0144] From the yield of YAL-SM and the related substance detection results of YAL-SM in Table 1 and Table 3, it can be seen that under the same other conditions, in the pre-treatment process of YAL-SM, Comparative Example 1 used methanol for refining treatment, and the yield of YAL-SM obtained was low, and the content of related substances was high. Comparative Example 2 adjusted the amount of DMF and the temperature of recrystallization. Compared with Example 1, recrystallization was performed at room temperature. Although more DMF was used, the related substances met the limit requirements, but the refining yield of YAL-SM decreased significantly. Comparative Example 3 only used a preparation process of one treatment, and its refining yield of YAL-SM was high (84%), but the impurity content in YAL-SM was too high, and the total impurity content was 3.4%, which obviously exceeded the limit value.

[0145] It can be seen that appropriate YAL-SM pretreatment conditions have a significant effect on simultaneously ensuring a high yield of YAL-SM and controlling the content of related substances.

[0146] Determination of related substances of Anlenox obtained in Examples 1 to 4 and Comparative Examples 1 to 9

[0147] Related Substance 1 Detection Method Determined by high performance liquid chromatography (Chinese Pharmacopoeia 2020 Edition, Part IV, General Rules 0512).

[0148] Test solution: Take the product, dissolve it in methanol and quantitatively dilute it to make a solution containing about 50 μg per 1 ml.

[0149] Control solution: Accurately measure an appropriate amount of the test solution and dilute it with methanol to make a solution containing approximately 0.5 μg per 1 ml.

[0150] System suitability solution: Take appropriate amount of YAL-1 and YAL-IM-A, place them in 50 ml volumetric flasks respectively, add methanol to dissolve and quantitatively dilute to make a solution containing approximately 0.2 mg per 1 ml as the impurity stock solution; take an appropriate amount of Anlenox reference substance, dissolve it in methanol, add appropriate amount of each impurity stock solution, and dilute with methanol to make a solution containing approximately 50 μg of Anlenox and 0.1 μg of each impurity per 1 ml.

[0151] Sensitivity solution: Accurately measure 2.5 ml of the control solution, place it in a 10 ml volumetric flask, dilute to the mark with methanol, and shake well.

[0152] Chromatographic conditions: using octadecylsilane bonded silica gel as filler (Welch Ultimate XB-C18, 4.6 mm × 250 mm, 5 μm or chromatographic column of equivalent performance); using 0.01 mol / L phosphoric acid aqueous solution as mobile phase A and methanol as mobile phase B, gradient elution was performed according to the table below; the flow rate was 1.0 ml per minute; the column temperature was 30°C; the detection wavelength was 244 nm; and the injection volume was 20 μl.

[0153] Table 4

[0154]

[0155] System suitability requirements: In the system suitability solution chromatogram, the separation between substances should meet the requirements; in the sensitivity solution chromatogram, the signal-to-noise ratio of the main component peak height should be greater than 10.

[0156] Determination method: Accurately measure the test solution and the reference solution, inject them into the liquid chromatograph respectively, and record the chromatogram.

[0157] If there are impurity peaks in the chromatogram of the limit test solution, the peak area of ​​YAL-1 and YAL-IM-A shall not be greater than 0.15 times (0.15%) of the main peak area of ​​the control solution, and the other individual impurities shall not be greater than 0.1 times (0.10%) of the main peak area of ​​the control solution. The total impurity peak area shall not be greater than 0.5 times (0.5%) of the main peak area of ​​the control solution.

[0158] Detection method for related substances 2 Determined by high performance liquid chromatography (Chinese Pharmacopoeia 2020 Edition, Part IV, General Rules 0512).

[0159] Test solution Take an appropriate amount of the product, add N,N-dimethylformamide to dissolve and quantitatively dilute to make a solution containing about 2.5 mg per 1 ml.

[0160] For the reference solution, take an appropriate amount of YAL-SM, add N,N-dimethylformamide to dissolve it and quantitatively dilute it to make a solution containing about 0.025 μg per 1 ml.

[0161] Chromatographic conditions: using octadecylsilane bonded silica gel as filler (Welch Ultimate XB-C18, 4.6 mm × 250 mm, 5 μm or chromatographic column of equivalent performance); using 0.01 mol / L phosphoric acid aqueous solution as mobile phase A and methanol as mobile phase B, gradient elution was performed according to the table below; the flow rate was 1.0 ml per minute; the column temperature was 30°C; the detection wavelength was 244 nm; and the injection volume was 20 μl.

[0162] Table 5

[0163]

[0164] Determination method: Accurately measure the test solution and the reference solution, inject them into the liquid chromatograph respectively, and record the chromatogram.

[0165] If the chromatogram of the test solution contains YAL-SM, the peak area calculated by the external standard method shall not exceed 0.15%.

[0166] Impurity information is shown in Table 6:

[0167] Table 6

[0168]

[0169]

[0170] The relevant material information of YAL obtained in Examples 1 to 4 and Comparative Examples 1 to 9 is shown in Table 7

[0171]

[0172]

[0173]

[0174] From the data of Table 1, Table 3 and Table 7, it can be seen that, under the same other conditions, Comparative Examples 1 to 3 show the influence of the raw material YAL-SM (refined or not) and its impurity content on the content of related substances in the final product YAL. Only when the YAL-SM is refined and the impurity content is low, can the content of related substances of YAL prepared using the corresponding YAL-SM be further guaranteed to meet the requirements. In Comparative Examples 1 and 2, although the yield of YAL-SM is low, the purity is high, and the corresponding YAL related substances meet the requirements. In Comparative Example 3, although the yield of YAL-SM is high, due to the high impurity content therein, the content of related substances of YAL finally obtained is also high.

[0175] Comparative Examples 4 to 8 show the effect of the preparation conditions of YAL in step 3) on the quality of the final YAL. Under the same other conditions, the YAL obtained by using toluene (Comparative Example 4) and NMP (Comparative Example 5) has a lower yield than that of Example 1, which is only 62% and 65%; the other single impurities in the related substances have exceeded the limit value of 0.1%, and the total impurity content has reached 0.43% and 0.42%, which is relatively high. Comparative Example 6 adopts a lower crystallization temperature (0-10°C). Compared with Example 1, the yield of YAL obtained in Comparative Example 6 is equivalent, but the types of impurities in the YAL obtained in Comparative Example 6 are more, and the content is also higher than that in Example 1, among which the content of other single impurities reaches 0.13%, exceeding the limit value of 0.10%. Comparative Example 8 increases the crystallization temperature (25°C). Compared with Example 1, the yield of YAL obtained in Comparative Example 8 is lower, and at the same time, the types of impurities in YAL are more, and the content of other single impurities reaches 0.11%, exceeding the limit value of 0.10%. Comparative Example 7 reduces the amount of pulping solvent, and the YAL yield obtained in Comparative Example 7 is lower than that in Example 1. At the same time, there are more types of impurities in YAL, and the content is also higher than that in Example 1. It can be seen that the type of solvent, the crystallization temperature and the amount of pulping solvent are coordinated with each other to effectively ensure that the yield of YAL-SM, the yield of YAL and YAL-related substances in the YAL preparation process have good effects.

[0176] The present application further compares the YAL prepared in Example 1 (Comparative Example 9) of the existing patent CN116444533A. The YAL-SM obtained according to the preparation process steps of the pretreatment, step 1) and step 2) of the present application has a refining yield of 62% under the conditions of patent CN116444533A, which is lower than that of Examples 1 to 4 of the present invention. At the same time, the impurity content in the YAL obtained using the refined YAL-SM also meets the limit requirements, except that compared with Examples 1 to 4 of the present invention, the impurity types are slightly more and the content is slightly higher, which may be due to the further use of DMSO.

[0177] It can be seen that the preparation process of the present invention constitutes a coordinated and unified system, and each link cooperates with each other, especially the pretreatment and the specific process conditions in step 3), which work together to ensure that the final YAL obtained has not only a high yield but also effectively controlled impurity content.

[0178] The embodiments of the present application are described above, but the present application is not limited to the above-mentioned specific implementation modes. The above-mentioned specific implementation modes are merely illustrative and not restrictive. Under the guidance of the present application, ordinary technicians in this field can also make many forms without departing from the purpose of the present application and the scope of protection of the claims, all of which are within the protection of the present application.

Claims

1. A method for refining an intermediate of Anlenox. It is characterized in that The steps include: Pretreatment: Mix the crude 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile with N,N-dimethylformamide, stir under heating conditions until the crude 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile is completely dissolved, then cool the mixture for crystallization, repeat the process 1 to 2 times to obtain a wet product of 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile, and dry the wet product of 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile to obtain 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile; wherein the solid-to-liquid ratio of the crude 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile to the N,N-dimethylformamide is 1:(2 to 3).

2. The method for purifying the intermediate of Anlenox according to claim 2, It is characterized in that In the pretreatment, the heating condition is a temperature of 40 to 60°C.

3. A method for preparing Anlenox, It is characterized in that The steps include: Step 1): reacting 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile with ethyl cyanoacetate under the action of piperidine to generate 2-amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid ethyl ester; Step 2): dissolving the ethyl 2-amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylate obtained in step 1) in anhydrous ethanol, and then adding sodium hydroxide to react to obtain a crude product of Anlenox; Step 3): purifying the crude product of Anlenox obtained in step 2) to obtain Anlenox; Wherein, the 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile is obtained by the method according to claim 1 or 2.

4. The method for preparing Anlenox according to claim 3, It is characterized in that The step 3) is performed as follows: The crude product of Anlenox is mixed with N,N-dimethylformamide, stirred and slurried under heating conditions, and then the mixture is cooled and crystallized, and drained until no liquid drips out to obtain wet product 1; then, a slurrying solvent is added to the wet product 1 to control the temperature and slurry, and wet product 2 is obtained after filtering, eluting, and draining, and the wet product 2 is dried to obtain Anlenox.

5. The method for preparing Anlenox according to claim 4, It is characterized in that In the step 3), the solid-to-liquid ratio of the crude Anlenox to the N,N-dimethylformamide is 1:(5-6).

6. The method for preparing Anlenox according to claim 5, It is characterized in that In the step 3), the solid-to-liquid ratio of the crude Anlenox to the pulping solvent is 1:(5-7).

7. The method for preparing Anlenox according to claim 6, It is characterized in that The pulping solvent in the step 3) is purified water.

8. The method for preparing Anlenox according to claim 7, It is characterized in that The temperature of the heating condition in the step 3) is 85-95°C.

9. The method for preparing Anlenox according to claim 8, It is characterized in that The temperature of the cooling and crystallization in the step 3) is 15-20°C.

10. Anlenox prepared by the method according to any one of claims 3 to 9.

Citation Information

Patent Citations

  • Refining method of amlexanox

    CN116444533A